Alto Neuroscience, Inc. (ANRO) vs MannKind Corporation (MNKD)
Alto Neuroscience, Inc. and MannKind Corporation are both Biotechnology companies. Alto Neuroscience, Inc. and MannKind Corporation are of similar size ($1.1B and $1.1B). Alto Neuroscience, Inc. has the higher net margin (0.00% vs −11.1%) and the lower return on invested capital (0.00% vs 2.36%). Across the 12 metrics below, MannKind Corporation leads on 7 and Alto Neuroscience, Inc. on 5.
Valuation
Profitability
| Metric | ANRO | MNKD | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 75.39% | 65.16% |
| Operating margin | 0.00% | 2.34% | 0.00% |
| Net margin | 0.00% | (11.08%) | 0.00% |
| Free cash flow margin | 0.00% | (4.61%) | 0.00% |
| Return on equity | (49.17%) | 71.36% | (57.72%) |
| Return on assets | (40.90%) | (7.62%) | (49.22%) |
| Return on invested capital | 0.00% | 2.36% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack